迈克生物(300463.SZ)：“血型鉴定及不规则抗体筛查质控品”取得产品注册证书

Core Viewpoint - The company has received a medical device registration certificate from the National Medical Products Administration for a new product, which is a quality control product for blood type identification and irregular antibody screening [1] Group 1: Product Development - The new product is designed to monitor the stability of laboratory testing systems and improve testing quality [1] - This quality control product adds to the company's portfolio, enhancing its market competitiveness [1] Group 2: Market Impact - The registration of the new product is expected to positively influence the company's market expansion and future operations [1]